Algernon Pharmaceuticals Files for Orphan Designation with the U.S. FDA for...

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial...

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Braxia Scientific Announces Court Approval of Class Action Settlement in Canada

PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data...

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine...

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation...

Load more